Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-25 6:33 pm Purchase | 2024-03-28 | 13G | Guerrilla RF, Inc. GUER | Lytton, Laurence W. | 1,088,179 9.990% | 1,088,179 (New Position) | Filing History |
| 2025-08-14 6:12 pm Purchase | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 51,391 1.600% | 51,391 (New Position) | Filing History |
| 2025-08-14 3:08 pm Purchase | 2025-06-30 | 13G | TELA Bio, Inc. TELA | Lytton, Laurence W. | 3,424,191 8.500% | 971,934 (+39.63%) | Filing History |
| 2025-08-14 1:56 pm Sale | 2025-06-30 | 13G | Creative Realities, Inc. CREX | Lytton, Laurence W. | 441,302 4.200% | -83,061 (-15.84%) | Filing History |
| 2025-08-14 1:54 pm Sale | 2025-06-30 | 13G | Electrovaya Inc. ELVA | Lytton, Laurence W. | 1,898,922 4.700% | -544,387 (-22.28%) | Filing History |
| 2025-08-14 1:51 pm Sale | 2025-06-30 | 13G | Exagen Inc. XGN | Lytton, Laurence W. | 216,840 1.000% | -936,648 (-81.20%) | Filing History |
| 2025-07-09 6:07 pm Sale | 2025-07-07 | 13G | Sonim Technologies, Inc. SONM | Lytton, Laurence W. | 987,465 5.600% | -212,535 (-17.71%) | Filing History |
| 2025-07-02 7:48 pm Sale | 2025-06-30 | 13G | Sonim Technologies, Inc. SONM | Lytton, Laurence W. | 1,200,000 11.200% | -866,916 (-41.94%) | Filing History |
| 2025-06-13 2:09 pm Purchase | 2025-06-09 | 13G | Aytu BioPharma, Inc. AYTU | Lytton, Laurence W. | 506,605 5.600% | 506,605 (New Position) | Filing History |
| 2025-05-16 5:41 pm Purchase | 2025-05-12 | 13G | Sonim Technologies, Inc. SONM | Lytton, Laurence W. | 2,066,916 19.300% | 1,200,000 (+138.42%) | Filing History |
| 2025-05-15 3:51 pm Sale | 2025-03-31 | 13G | Evoke Pharma, Inc. EVOK | Lytton, Laurence W. | 61,274 3.900% | -13,483 (-18.04%) | Filing History |
| 2025-05-15 3:50 pm Sale | 2025-03-31 | 13G | SmartKem, Inc. SMTK | Lytton, Laurence W. | 222,721 4.900% | -110,612 (-33.18%) | Filing History |
| 2025-05-15 3:49 pm Sale | 2025-03-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | Lytton, Laurence W. | 1,295,288 2.600% | -764,634 (-37.12%) | Filing History |
| 2025-05-15 3:29 pm Sale | 2025-03-31 | 13G | Creative Realities, Inc. CREX | Lytton, Laurence W. | 524,363 5.000% | -137,028 (-20.72%) | Filing History |
| 2025-05-15 3:27 pm Sale | 2025-03-31 | 13G | Biofrontera Inc. BFRI | Lytton, Laurence W. | 306,700 3.500% | -248,184 (-44.73%) | Filing History |
| 2025-04-16 2:11 pm Purchase | 2025-04-15 | 13G | Xtant Medical Holdings, Inc. XTNT | Lytton, Laurence W. | 9,463,442 6.800% | 9,463,442 (New Position) | Filing History |
| 2025-02-24 11:48 am Purchase | 2025-02-20 | 13G | Sonim Technologies, Inc. SONM | Lytton, Laurence W. | 866,916 17.800% | 401,400 (+86.23%) | Filing History |
| 2025-02-13 3:55 pm Sale | 2024-12-31 | 13G | Creative Realities, Inc. CREX | Lytton, Laurence W. | 661,391 6.300% | -122,609 (-15.64%) | Filing History |
| 2025-02-13 3:49 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 131,849 8.800% | -14,483 (-9.90%) | Filing History |
| 2025-02-13 3:45 pm Purchase | 2024-01-31 | 13G | Duos Technologies Group, Inc. DUOT | Lytton, Laurence W. | 427,002 4.990% | 26,434 (+6.60%) | Filing History |